MDMA/PTSD US Intern Study

MDMA-Assisted Psychotherapy in the Treatment of Posttraumatic Stress Disorder (PTSD) Intern Study

The next phase (Phase 3) of our clinical development plan for MDMA-assisted psychotherapy for PTSD will require many more male/female co-therapist teams than are currently available. Finding a cost-effective and sustainable way to recruit effective therapists is therefore a top priority.

In this pilot study, we will investigate the effectiveness of MDMA-assisted psychotherapy for PTSD when one member of the standard male/female co-therapist team is a healthcare intern (being trained in therapy, social work, or nursing). The other member of the team will be a professional therapist trained in our treatment method. As interns work for free in exchange for fulfilling required training hours under professional supervision, this approach would reduce costs and train the next generation of psychedelic therapists.

Principal Investigator: Marcela Ot'alora, M.A., L.P.C.
Location: Boulder, CO

Subjects will be U.S. veterans with PTSD, mostly from Iraq, Aghanistan, or Vietnam, along with survivors of childhood sexual abuse, assault, rape, and others.

This study has been approved by the Institutional Review Board and cleared by the FDA.

This study is expected to cost $250,000, of which $125,000 remains to be raised.

View the timeline for this study.